| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| ALCAM | Human ALCAM Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $260.00 200ug | |||
| ALCAM | Human ALCAM Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $280.00 200ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Praluzatamab ravtansine | CX-2009 | Phase 2 Clinical | Cytomx Therapeutics Inc, Immunogen Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |